1-(5-Bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethylpropan-1-one

Catalog No.: 
ACAFXR892
CAS No.: 
1250680-29-5
Molecular Formula: 
C11H12BrClO2
Molecular Weight: 
291.57
1-(5-Bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethylpropan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$115.00InquiryInquiry
1g95%$328.00InquiryInquiry
5g95%$954.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethylpropan-1-one
IUPAC Name1-(5-bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethylpropan-1-one
MDL No.MFCD16742950
Molecular FormulaC11H12BrClO2
Molecular Weight291.57
SMILESCC(C)(C)C(C1=CC(Br)=CC(Cl)=C1O)=O
InChI KeyXXXODFDMPVRFEP-UHFFFAOYSA-N
Synonym1-Propanone, 1-(5-bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethyl-;1-(5-Bromo-3-chloro-2-hydroxyphenyl)-2,2-dimethylpropan-1-one
CAS No.1250680-29-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACAFXR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWOJG478 route compound structure diagram
    ACWOJG4783964-56-5In Stock
  4. Then
  5. ACAFXR892 route product structure diagram
    ACAFXR8921250680-29-5
Inquiry

2. ACAFXR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAFXR892 route product structure diagram
    ACAFXR8921250680-29-5
Inquiry

3. ACAFXR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAFXR892 route product structure diagram
    ACAFXR8921250680-29-5
Inquiry

Comments (0)